The wall is permeable to an external body fluid but impermeable to the agent and has a passageway for delivering the agent to the body. 3,845,770, issued to Theeuwes et al., is directed to an osmotic device for the controlled release of an agent which comprises a semi-permeable membrane that surrounds a compartment which contains the agent. 3,279,996, issued to Long et al., discloses a method and means for the controlled release of a therapeutic agent into a living organism by implanting within the body of that organism a capsule formed of silicone rubber and containing a therapeutic agent soluble in and capable of diffusing through the rubber to its outer surface at a constant rate. A61P15/00- Drugs for genital or sexual disorders ContraceptivesĪlso well known are a number of devices which can be implanted inside the body of the living being and are constructed such that the beneficial agent can diffuse out of the device.A61P- SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS.A61K9/0019- Injectable compositions Intramuscular, intravenous, arterial, subcutaneous administration Compositions to be administered through the skin in an invasive manner.A61K9/0012- Galenical forms characterised by the site of application.A61K9/00- Medicinal preparations characterised by special physical form.A61K38/27- Growth hormone (Somatotropin).A61K38/17- Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof from animals from humans.A61K38/16- Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof.A61K38/00- Medicinal preparations containing peptides.dimethyl sulfoxide, docusate, sodium lauryl sulfate or aminosulfonic acids natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite carriers or inert additives Targeting or modifying agents chemically bound to the active ingredient A61K47/00- Medicinal preparations characterised by the non-active ingredients used, e.g.A61K- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES.A61- MEDICAL OR VETERINARY SCIENCE HYGIENE.Anticipated expiration legal-status Critical Status Expired - Lifetime legal-status Critical Current Links CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCHERING-PLOUGH ANIMAL HEALTH CORPORATION Assigned to BIOGEN IDEC MA, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Priority to US07/031,273 priority Critical patent/US4888416A/en Priority to AU11728/88A priority patent/AU620540B2/en Priority to NZ223533A priority patent/NZ223533A/en Priority to EP88302317A priority patent/EP0285286A1/en Priority to CN198888101780A priority patent/CN88101780A/en Priority to IL85893A priority patent/IL85893A0/en Priority to JP63073474A priority patent/JPS63269996A/en Publication of US4888416A publication Critical patent/US4888416A/en Application granted granted Critical Assigned to SCHERING-PLOUGH ANIMAL HEALTH CORPORATION reassignment SCHERING-PLOUGH ANIMAL HEALTH CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DRENGLER, SUSAN M., JANSKI, ALVIN M. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by International Minerals and Chemical Corp filed Critical International Minerals and Chemical Corp Assigned to INTERNATIONAL MINERALS & CHEMICAL CORPORATION reassignment INTERNATIONAL MINERALS & CHEMICAL CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST. Original Assignee International Minerals and Chemical Corp Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Drengler Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Lifetime Application number US07/031,273 Inventor Alvin M. Google Patents Method for stabilizing somatotropinsÄownload PDF Info Publication number US4888416A US4888416A US07/031,273 US3127387A US4888416A US 4888416 A US4888416 A US 4888416A US 3127387 A US3127387 A US 3127387A US 4888416 A US4888416 A US 4888416A Authority US United States Prior art keywords somatotropin detergent product dried protein Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US4888416A - Method for stabilizing somatotropins US4888416A - Method for stabilizing somatotropins
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |